Skip to main content
Fig. 4 | Biology of Sex Differences

Fig. 4

From: Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality

Fig. 4

Sex-specific biomarker associations and all-cause mortality. A Sex divided GDF-15 level comparison in alive patients (females n = 71; males n = 127), and deceased patients (females n = 7; males n = 21). B Sex divided YKL-40 level comparison in alive patients (females n = 70; males n = 123), and deceased patients (females n = 7; males n = 21). Data presented median (IQR). *p < 0.05, **p < 0.01, ***p < 0.001, age adjusted

Back to article page